| Q33617524 | A Brief History of Cardiac Syndrome X: A Biochemical View |
| Q36181453 | ABO-Rh blood groups distribution in cardiac syndrome X patients |
| Q24613443 | Angina in Women without Obstructive Coronary Artery Disease |
| Q47157935 | Association of Inflammation and Endothelial Dysfunction with Coronary Microvascular Resistance in Patients with Cardiac Syndrome X. |
| Q40436971 | Association of endothelial dysfunction and cytotoxin-associated gene A-positive Helicobacter pylori in patients with cardiac syndrome X. |
| Q33809242 | Cardiovascular outcomes of a positive nuclear stress test but negative coronary angiography in a multiethnic male predominant cohort |
| Q53396320 | Coronary artery calcium score assessed by a 64 multislice computed tomography and early indexes of functional and structural vascular remodeling in cardiac syndrome X patients. |
| Q26772062 | Diagnosis of coronary microvascular dysfunction - Present status |
| Q33323355 | Direct isolation, culture and transplant of mouse skeletal muscle derived endothelial cells with angiogenic potential |
| Q90150808 | Echocardiographic measurement of epicardial adipose tissue thickness in patients with microvascular angina |
| Q43117871 | Effects of nebivolol therapy on endothelial functions in cardiac syndrome X. |
| Q42409955 | Endothelial progenitor cells, endothelial cell dysfunction and much more: observations from cardiac syndrome X |
| Q88107768 | Fragmented QRS frequency in patients with cardiac syndrome X |
| Q37723867 | Fragmented QRS frequency in patients with cardiac syndrome X. |
| Q35733431 | Frequency of Helicobacter pylori and cytotoxine associated gene A antibodies in patients with cardiac syndrome X. |
| Q47770827 | Investigation of MTHFR gene C677T polymorphism in cardiac syndrome X patients. |
| Q48324048 | Left atrial volume and function in patients with cardiac syndrome X assessed by real time three-dimensional echocardiography. |
| Q37250853 | Lipid Profile in Cardiac Syndrome X: Association with Helicobacter pylori |
| Q35093085 | Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management |
| Q64994858 | NONOBSTRUCTIVE CORONARY ARTERY DISEASE - CLINICAL RELEVANCE, DIAGNOSIS, MANAGEMENT AND PROPOSAL OF NEW PATHOPHYSIOLOGICAL CLASSIFICATION. |
| Q37270966 | Outcomes in patients with abnormal myocardial perfusion imaging and normal coronary angiogram. |
| Q85176448 | Selective estrogen receptor modulators promising for cardiac syndrome X |
| Q33781870 | Serum ADMA concentration-- an independent factor determining FMD impairment in cardiac syndrome X |
| Q88253973 | Serum endocan levels in patients with cardiac syndrome X |
| Q48109159 | The APEX trial: Effects of allopurinol on exercise capacity, coronary and peripheral endothelial function, and natriuretic peptides in patients with cardiac syndrome X. |
| Q47152372 | The prognostic value of asymmetric dimethylarginine in patients with cardiac syndrome X. |
| Q42080063 | The usefulness of plateletcrit to predict cardiac syndrome X in patients with normal coronary angiogram |